1. Home
  2. RLMD vs LMFA Comparison

RLMD vs LMFA Comparison

Compare RLMD & LMFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLMD
  • LMFA
  • Stock Information
  • Founded
  • RLMD 2004
  • LMFA 2008
  • Country
  • RLMD United States
  • LMFA United States
  • Employees
  • RLMD N/A
  • LMFA N/A
  • Industry
  • RLMD Biotechnology: Pharmaceutical Preparations
  • LMFA Finance: Consumer Services
  • Sector
  • RLMD Health Care
  • LMFA Finance
  • Exchange
  • RLMD Nasdaq
  • LMFA Nasdaq
  • Market Cap
  • RLMD 11.5M
  • LMFA 9.2M
  • IPO Year
  • RLMD N/A
  • LMFA 2015
  • Fundamental
  • Price
  • RLMD $0.39
  • LMFA $2.04
  • Analyst Decision
  • RLMD Hold
  • LMFA Hold
  • Analyst Count
  • RLMD 4
  • LMFA 1
  • Target Price
  • RLMD $4.25
  • LMFA N/A
  • AVG Volume (30 Days)
  • RLMD 881.7K
  • LMFA 81.8K
  • Earning Date
  • RLMD 03-18-2025
  • LMFA 11-13-2024
  • Dividend Yield
  • RLMD N/A
  • LMFA N/A
  • EPS Growth
  • RLMD N/A
  • LMFA N/A
  • EPS
  • RLMD N/A
  • LMFA N/A
  • Revenue
  • RLMD N/A
  • LMFA $12,838,084.00
  • Revenue This Year
  • RLMD N/A
  • LMFA N/A
  • Revenue Next Year
  • RLMD N/A
  • LMFA N/A
  • P/E Ratio
  • RLMD N/A
  • LMFA N/A
  • Revenue Growth
  • RLMD N/A
  • LMFA 27.81
  • 52 Week Low
  • RLMD $0.34
  • LMFA $1.84
  • 52 Week High
  • RLMD $7.22
  • LMFA $6.11
  • Technical
  • Relative Strength Index (RSI)
  • RLMD 27.23
  • LMFA 39.76
  • Support Level
  • RLMD $0.36
  • LMFA $1.90
  • Resistance Level
  • RLMD $0.49
  • LMFA $2.37
  • Average True Range (ATR)
  • RLMD 0.04
  • LMFA 0.19
  • MACD
  • RLMD 0.07
  • LMFA 0.01
  • Stochastic Oscillator
  • RLMD 12.64
  • LMFA 25.35

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About LMFA LM Funding America Inc.

LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining Operations, which generate the majority of its revenue.

Share on Social Networks: